On February 18, 2019 Oncopeptides AB (Nasdaq Stockholm, ONCO) reported that the Company will release its Year-end Report on 22 February at 8:00 am CET (Press release, Oncopeptides, FEB 18, 2019, View Source [SID1234533530]). The report will be available on the Company’s web site at www.oncopeptides.com.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The company’s CEO Jakob Lindberg will summarize the financial year 2018 and address questions from investors, analysts and media at 14:00 CET, 22 February.
An audiocast to the presentation will be available at:
Time for webcast – 14:00 (CET) on 22 February
Dial in number from Sweden: +46856642706
Dial in number from UK: +443333009270
Dial in number US: +18335268382